Tuesday, March 17, 2026

North Korea “This Year Is Completion Year”… Nation Wide Hospital·Factory Construction Performance Display[Daily North Korea]

North Korea celebrates achievements in local development and construction under Kim Jong Un, marking a year of historic milestones.

Revolutionizing Pharma: How LG CNS’s Agentic AI is Set to Transform Drug Development in South Korea

LG CNS expands its AI Transformation business into pharma, enhancing drug development with AI-driven platforms and automation services.

The Birth of ‘Izna’: A New Chapter in K-Pop Begins

The final debut members of I-LAND2 have...

Tag: lung cancer

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

NCCN Endorses Leclaza and Rybrevant Combo as Top Lung Cancer Treatment: What You Need to Know

NCCN guidelines now classify Leclaza + Rybrevant as a preferred first-line treatment for lung cancer, enhancing patient access and management.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Cigarettes vs. DNA: Study Shows Smoking Is the Real Cancer Trigger

A study shows that smoking for over 20 years increases small-cell lung cancer risk by 54 times, highlighting smoking's dangers.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

New South Korean Tech Detects Lung Cancer Early with Only 5 Drops of Blood

A South Korean team developed a blood test for early lung cancer detection, achieving 100% accuracy in identifying key mutations.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.